Log in to save to my catalogue

Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer's Agents Targeting BACE...

Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer's Agents Targeting BACE...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A634849269

Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer's Agents Targeting BACE1 and PPAR[gamma]

About this item

Full title

Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer's Agents Targeting BACE1 and PPAR[gamma]

Publisher

John Wiley & Sons, Inc

Journal title

Journal of chemistry, 2020-06, Vol.2020

Language

English

Formats

Publication information

Publisher

John Wiley & Sons, Inc

More information

Scope and Contents

Contents

In the last few decades, Alzheimer's disease (AD) has emerged as a serious global problem, and it has been considered as the most common type of dementia. PPAR[gamma] and beta-secretase 1 (BACE1) are considered as potential targets for Alzheimer's disease management. In the same time, sulfonylureas and sulfonamides have been confirmed to have PPAR[...

Alternative Titles

Full title

Screening of Some Sulfonamide and Sulfonylurea Derivatives as Anti-Alzheimer's Agents Targeting BACE1 and PPAR[gamma]

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A634849269

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A634849269

Other Identifiers

ISSN

2090-9063

DOI

10.1155/2020/1631243

How to access this item